A
2.20
-0.15 (-6.38%)
| Previous Close | 2.35 |
| Open | 2.32 |
| Volume | 13,845,381 |
| Avg. Volume (3M) | 6,209,636 |
| Market Cap | 910,694,400 |
| Price / Earnings (Forward) | 178.57 |
| Price / Sales | 0.260 |
| Price / Book | 3.33 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2025 - 8 Aug 2025 |
| Profit Margin | -4.29% |
| Operating Margin (TTM) | -6.87% |
| Diluted EPS (TTM) | -0.610 |
| Quarterly Revenue Growth (YOY) | 44.20% |
| Total Debt/Equity (MRQ) | 9.34% |
| Current Ratio (MRQ) | 1.26 |
| Operating Cash Flow (TTM) | -57.78 M |
| Levered Free Cash Flow (TTM) | -38.34 M |
| Return on Assets (TTM) | -10.22% |
| Return on Equity (TTM) | -44.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | agilon health, inc. | Bullish | Bearish |
AIStockmoo Score
0.3
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.25 |
|
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 2.20% |
| % Held by Institutions | 95.54% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Clayton, Dubilier & Rice, Llc | 31 Dec 2024 | 100,000,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 8.50 (Bernstein, 286.36%) | Buy |
| Median | 5.00 (127.27%) | |
| Low | 3.00 (Barclays, 36.36%) | Sell |
| Average | 5.36 (143.64%) | |
| Total | 3 Buy, 3 Hold, 1 Sell | |
| Avg. Price @ Call | 4.21 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 13 May 2025 | 5.00 (127.27%) | Buy | 2.70 |
| Barclays | 08 May 2025 | 3.00 (36.36%) | Sell | 3.22 |
| Goldman Sachs | 08 May 2025 | 5.00 (127.27%) | Hold | 3.22 |
| Citigroup | 25 Apr 2025 | 5.00 (127.27%) | Buy | 3.90 |
| Baird | 15 Apr 2025 | 5.00 (127.27%) | Hold | 5.53 |
| TD Cowen | 15 Apr 2025 | 6.00 (172.73%) | Hold | 5.53 |
| Bernstein | 08 Apr 2025 | 8.50 (286.36%) | Buy | 5.36 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 19 May 2025 | Announcement | agilon health to Participate in Bernstein's 41st Annual Strategic Decisions Conference |
| 06 May 2025 | Announcement | agilon health Reports First Quarter 2025 Results |
| 04 Apr 2025 | Announcement | agilon health to Participate in BofA Securities 2025 Health Care Conference |
| 25 Mar 2025 | Announcement | agilon health Sets Date to Report First Quarter 2025 Financial Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |